Family Medicine · Glendale, CA
NPI
1619015195
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1220 S Central Ave Ste 205
Glendale, CA, 91204
Phone (818) 247-7677
Groups this clinician bills Medicare through
Medicare paid, 2024
$464K
8,036 services
Medicare patients, 2024
564
Average age 74
Drug cost, 2024
$4.7M
46,618 prescriptions
Company payments, 2025
$15
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Manvel M Mazmanyan was code 99213 (office e&m - established), 1,949 times for 552 patients. In total Manvel M Mazmanyan billed 8,036 services in 39 codes, and Medicare paid $464K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,949 | 552 | $72.64 | $142K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,798 | 488 | $52.00 | $93K |
| 36415 Venipuncture Blood Collection | Office | 957 | 524 | $8.65 | $8,278 |
| 99214 Office E&M - Established | Office | 861 | 495 | $101.57 | $87K |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 498 | 498 | $26.81 | $13K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 495 | 495 | $21.10 | $10K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 491 | 491 | $140.31 | $69K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 154 | 100 | $44.39 | $6,836 |
| 96372 Injection Administration | Office | 150 | 51 | $11.08 | $1,662 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 109 | 109 | $21.09 | $2,299 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 108 | 79 | $34.60 | $3,737 |
| 99212 Office E&M - Established | Office | 88 | 80 | $46.08 | $4,055 |
| 99406 Behavioral Health Services | Office | 74 | 74 | $15.59 | $1,153 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 63 | 63 | $26.81 | $1,689 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 48 | 17 | $0.75 | $36.18 |
By year: 2022 $393K for 6,588 services; 2023 $413K for 7,146 services; 2024 $464K for 8,036 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 957 | 524 | $8.65 | $8,278 |
Medicare prescription drug claims, 2024
In 2024, the drug Manvel M Mazmanyan prescribed most often to Medicare patients was Amlodipine Besylate, with 1,902 prescriptions and refills. In total Manvel M Mazmanyan wrote 46,618 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,902 | 2,167 | 226 | $2,296 |
| Gabapentin Generic | 1,724 | 1,907 | 191 | $4,927 |
| Metoprolol Succinate Generic | 1,692 | 1,908 | 186 | $8,204 |
| Baclofen Generic | 1,575 | 1,810 | 180 | $6,234 |
| Vascepa Icosapent Ethyl | 1,422 | 1,625 | 186 | $318K |
| Metformin Hcl Generic | 1,378 | 1,601 | 147 | $1,748 |
| Atorvastatin Calcium Generic | 1,240 | 1,375 | 132 | $3,006 |
| Rosuvastatin Calcium Generic | 1,148 | 1,316 | 141 | $3,745 |
| Tamsulosin Hcl Generic | 957 | 1,068 | 110 | $3,796 |
| Dexlansoprazole Dr Dexlansoprazole | 921 | 1,086 | 133 | $174K |
| Meclizine Hcl Generic | 857 | 956 | 106 | $5,708 |
| Meloxicam Generic | 817 | 929 | 106 | $1,059 |
| Ezetimibe Generic | 778 | 888 | 82 | $5,753 |
| Pantoprazole Sodium Generic | 747 | 824 | 92 | $2,454 |
| Hydralazine Hcl Generic | 711 | 752 | 77 | $3,374 |
Brand drugs: 9,387 claims; generic drugs: 36,717 claims; opioid claims: 274.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Manvel M Mazmanyan $15 ($15 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $15.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.